156 related articles for article (PubMed ID: 16973575)
1. Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep.
Debacq C; Gillet N; Asquith B; Sanchez-Alcaraz MT; Florins A; Boxus M; Schwartz-Cornil I; Bonneau M; Jean G; Kerkhofs P; Hay J; Théwis A; Kettmann R; Willems L
J Virol; 2006 Oct; 80(19):9710-9. PubMed ID: 16973575
[TBL] [Abstract][Full Text] [Related]
2. Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep.
Florins A; Gillet N; Asquith B; Debacq C; Jean G; Schwartz-Cornil I; Bonneau M; Burny A; Reichert M; Kettmann R; Willems L
J Virol; 2006 Dec; 80(24):11998-2008. PubMed ID: 17035334
[TBL] [Abstract][Full Text] [Related]
3. Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease.
Florins A; Boxus M; Vandermeers F; Verlaeten O; Bouzar AB; Defoiche J; Hubaux R; Burny A; Kettmann R; Willems L
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):1-7. PubMed ID: 18513803
[TBL] [Abstract][Full Text] [Related]
4. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.
Debacq C; Asquith B; Kerkhofs P; Portetelle D; Burny A; Kettmann R; Willems L
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10048-53. PubMed ID: 12119390
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte activators elicit bovine leukemia virus expression differently as asymptomatic infection progresses.
Kidd LC; Radke K
Virology; 1996 Mar; 217(1):167-77. PubMed ID: 8599201
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor necrosis factor-alpha in IgM+ B-cells from bovine leukemia virus-infected lymphocytotic sheep.
Usui T; Konnai S; Ohashi K; Onuma M
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):296-301. PubMed ID: 16621026
[TBL] [Abstract][Full Text] [Related]
7. Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep.
Aida Y; Miyasaka M; Okada K; Onuma M; Kogure S; Suzuki M; Minoprio P; Levy D; Ikawa Y
Am J Vet Res; 1989 Nov; 50(11):1946-51. PubMed ID: 2559634
[TBL] [Abstract][Full Text] [Related]
8. Chemokine networks and in vivo T-lymphocyte trafficking in nonhuman primates.
Clay CC; Rodrigues DS; Brignolo LL; Spinner A; Tarara RP; Plopper CG; Leutenegger CM; Esser U
J Immunol Methods; 2004 Oct; 293(1-2):23-42. PubMed ID: 15541274
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced cytotoxic T lymphocytes protect against retroviral challenge.
Hislop AD; Good MF; Mateo L; Gardner J; Gatei MH; Daniel RC; Meyers BV; Lavin MF; Suhrbier A
Nat Med; 1998 Oct; 4(10):1193-6. PubMed ID: 9771756
[TBL] [Abstract][Full Text] [Related]
10. Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep.
Merimi M; Klener P; Szynal M; Cleuter Y; Bagnis C; Kerkhofs P; Burny A; Martiat P; Van den Broeke A
Retrovirology; 2007 Jul; 4():51. PubMed ID: 17645797
[TBL] [Abstract][Full Text] [Related]
11. T lymphocyte migration to lymph nodes is maintained during homeostatic proliferation.
Kodera M; Grailer JJ; Karalewitz AP; Subramanian H; Steeber DA
Microsc Microanal; 2008 Jun; 14(3):211-24. PubMed ID: 18312727
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep.
Usui T; Konnai S; Tajima S; Watarai S; Aida Y; Ohashi K; Onuma M
J Vet Med Sci; 2003 Nov; 65(11):1201-5. PubMed ID: 14665749
[TBL] [Abstract][Full Text] [Related]
13. Host soluble factors that regulate the synthesis of the major core protein of the bovine leukemia virus (BLV) in a naturally infected neoplastic B-cell line.
Gutiérrez S; Ceriani C; Juliarena M; Ferrer JF
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):246-58. PubMed ID: 19497626
[TBL] [Abstract][Full Text] [Related]
14. B cells from bovine leukemia virus- (BLV) infected sheep with hematological disorders express the CD5 T cell marker.
Letesson JJ; Mager A; Mammerickx M; Burny A; Depelchin A
Leukemia; 1990 May; 4(5):377-9. PubMed ID: 1697010
[TBL] [Abstract][Full Text] [Related]
15. Porcine circovirus type 2 (PCV2) distribution and replication in tissues and immune cells in early infected pigs.
Yu S; Opriessnig T; Kitikoon P; Nilubol D; Halbur PG; Thacker E
Vet Immunol Immunopathol; 2007 Feb; 115(3-4):261-72. PubMed ID: 17175030
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma expression associated with suppression of bovine leukemia virus at the early phase of infection in sheep.
Usui T; Konnai S; Ohashi K; Onuma M
Vet Immunol Immunopathol; 2007 Jan; 115(1-2):17-23. PubMed ID: 17064782
[TBL] [Abstract][Full Text] [Related]
17. Differential preferences in serosal homing and distribution of peritoneal B-cell subsets revealed by in situ CFSE labeling.
Lábadi A; Balogh P
Int Immunol; 2009 Sep; 21(9):1047-56. PubMed ID: 19625383
[TBL] [Abstract][Full Text] [Related]
18. [Malignant lymphoma and lymphoid leukemia induced in sheep by a bovine leukemia virus: a model of B-lymphocyte malignant hemopathy].
Parodi AL
Bull Acad Natl Med; 1988 Oct; 172(7):895-905. PubMed ID: 2854491
[No Abstract] [Full Text] [Related]
19. Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus.
Ferens WA; Haruna J; Cobbold R; Hovde CJ
J Vet Sci; 2008 Dec; 9(4):375-9. PubMed ID: 19043312
[TBL] [Abstract][Full Text] [Related]
20. A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep.
Pomier C; Alcaraz MT; Debacq C; Lançon A; Kerkhofs P; Willems L; Wattel E; Mortreux F
Retrovirology; 2009 Apr; 6():30. PubMed ID: 19344505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
